6.69
Tvardi Therapeutics Inc 주식(TVRD)의 최신 뉴스
Tvardi Therapeutics: 'Sell' Rating On IPF Drug TTI-101 Advancement Uncertainty (TVRD) - Seeking Alpha
Why Is Tvardi Therapeutics Stock Falling Today?Tvardi Therapeutics (NASDAQ:TVRD) - Benzinga
Tvardi Therapeutics stock plummets as Oppenheimer slashes price target By Investing.com - Investing.com Australia
BTIG lowers Tvardi Therapeutics stock price target to $15 on IPF trial setback - Investing.com Canada
Gold Rises Over 3%; Tvardi Therapeutics Shares Plunge - Benzinga
Measuring Tvardi Therapeutics Inc.’s beta against major indicesJuly 2025 Sentiment & Fast Gain Swing Trade Alerts - newser.com
Cantor downgrades Tvardi Therapeutics, sees ‘no path forward in IPF’ - TipRanks
Live market analysis of Tvardi Therapeutics Inc.2025 Risk Factors & Real-Time Stock Entry Alerts - newser.com
Why Did Tvardi Therapeutics Stock Plummet 87% Pre-Market Today? - Menafn.com
Will Tvardi Therapeutics Inc. benefit from macro trendsJuly 2025 Update & Breakout Confirmation Trade Signals - newser.com
Barclays Initiates Tvardi Therapeutics at Overweight With $61 Price Target - MarketScreener
Why Is Tvardi Therapeutics Stock (TVRD) Down 85% Today? - TipRanks
Does Tvardi Therapeutics Inc. stock trade at a discount to peersJuly 2025 Reactions & Safe Capital Growth Tips - newser.com
Tvardi Therapeutics' Potential Lung Disease Treatment Fails to Meet Goals; Shares Decline Pre-Bell - MarketScreener
Published on: 2025-10-13 07:20:38 - newser.com
Using RSI to spot recovery in Tvardi Therapeutics Inc.2025 Valuation Update & Reliable Momentum Entry Alerts - newser.com
Using AI based signals to follow Tvardi Therapeutics Inc.2025 Year in Review & Real-Time Stock Entry Alerts - newser.com
Tvardi Therapeutics stock plunges after failed IPF trial data - Investing.com
Barclays initiates coverage on Tvardi Therapeutics stock with Overweight rating - Investing.com
Can swing trading help recover from Tvardi Therapeutics Inc. losses2025 Market Overview & AI Enhanced Execution Alerts - newser.com
Using data models to predict Tvardi Therapeutics Inc. stock movement2025 Earnings Surprises & Community Consensus Trade Alerts - newser.com
Tvardi Therapeutics, Inc. (NASDAQ:TVRD) most popular amongst retail investors who own 57% of the shares, institutions hold 26% - Yahoo Finance
Tvardi Therapeutics Inc. stock volume spike explainedJuly 2025 Pullbacks & Weekly Market Pulse Updates - newser.com
Published on: 2025-10-10 08:50:26 - newser.com
Best data tools to analyze Tvardi Therapeutics Inc. stockJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com
Tvardi Therapeutics Inc. stock daily chart insightsJuly 2025 Pullbacks & Weekly Top Gainers Alerts - newser.com
Is Tvardi Therapeutics Inc 69C a good long term investmentStock Rotation Strategies & Get Tomorrow’s Winners Today With AI - earlytimes.in
Published on: 2025-10-06 07:23:43 - newser.com
Order flow analysis tools used on Tvardi Therapeutics Inc.July 2025 Short Interest & Weekly Stock Performance Updates - newser.com
Is it time to cut losses on Tvardi Therapeutics Inc.Trade Exit Summary & Entry Point Confirmation Alerts - newser.com
Will Tvardi Therapeutics Inc. (69C) stock beat value stocks2025 Market Trends & Weekly Watchlist for Hot Stocks - newser.com
Why analysts remain bullish on Tvardi Therapeutics Inc. stockAnalyst Downgrade & Risk Controlled Daily Plans - newser.com
Will Tvardi Therapeutics Inc. price bounce be sustainableBull Run & Entry Point Confirmation Alerts - newser.com
Is Tvardi Therapeutics Inc. stock cheap at current valuationJuly 2025 Trends & Weekly Setup with ROI Potential - newser.com
What dividend safety score for Tvardi Therapeutics Inc. stockEntry Point & Verified Momentum Watchlists - newser.com
What the charts say about Tvardi Therapeutics Inc. today2025 Volume Leaders & Intraday High Probability Setup Alerts - newser.com
Tvardi Therapeutics, Inc. (NASDAQ:TVRD) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
자본화:
|
볼륨(24시간):